Illumina strives to advance awareness of the importance of genetics and health. We recognize that education and clinical research are key to achieving this goal.
Illumina is dedicated to providing medical genetics education, supporting independent medical education and investing in clinical studies. All of these endeavors are done in alignment with our core values and ethical responsibilities.
Illumina is committed to providing healthcare professionals with accurate, unbiased and balanced information and education. Our education begins with basic genetic concepts and encompasses specific areas of focus including obstetrics, oncology and rare diseases. This includes Continuing Medical Education (CME) activities.
This information is not a substitute for the exercise of the healthcare provider’s professional judgment in providing clinical services.
Illumina supports Continuing Medical Education (CME) activities to help enhance healthcare providers’ knowledge, with the goal of improving patient care.
Learn more about the latest molecular techniques used in cancer diagnosis, prognosis and therapy including next-generation sequencing and microarraysView CME Activity
A discussion on the benefits and limitations of prenatal screening options including noninvasive prenatal testingView CME Activity
Illumina is committed to the advancement of medicine and improvement of patient care by increasing awareness of the utility of genomics in medicine. We provide grants in support of accredited and non-accredited educational activities for healthcare providers and allied health professionals. Grant requests that align with our clinical areas of focus are given priority.
All grant proposals are reviewed for compliance with our policies and relevant legal and industry requirements, including guidelines set forth by the Accreditation Council for Continuing Medical Education (ACCME). Requests for an educational grant should be submitted at least 90 days prior to the proposed program date and/or accreditation date. Please submit requests to IMEDgrants@illumina.com.
Clinical trials are essential to Illumina’s product development and clinical pipeline. We are committed to patient safety and value the importance of transparency. We are dedicated to publically sharing clinical trial information and data. For more information about Illumina’s involvement in clinical trials, please visit clinicaltrials.gov.